Levitee Labs has acquired its first five addiction clinics, three specialized pharmacies and pioneering technology company that cumulatively treat tens...
Company to also host R&D Day on Thursday, November 11 in New York City and via video webcast SOUTH SAN...
BOULDER, Colo., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (Nasdaq: BBI) (“Brickell”), a clinical-stage pharmaceutical company striving to...
ROCKVILLE, Md., Oct. 28, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on...
SAN DIEGO, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing...
Consolidated Net Revenue of $12.2 Million Down 2% vs. Third Quarter of 2020 and Up 14% vs. Second Quarter of 2021U.S....
-Product is the first generic alternative to one of the highest priced pharmaceutical products in the worldDEER PARK, Ill., Oct....
CHARLOTTESVILLE, Va., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company...
Reports record revenue of $178.2 million for the quarter, representing year-over-year growth of 89% and organic growth of 77%Raises revenue...
ALPHARETTA, Ga., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to...
ANN ARBOR, Mich., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the...
Press Release 28 October 2021 Immunicum to Host Investor Meeting with CEO Immunicum AB (publ; IMMU.ST) today announced that on...
Novadip Biosciences announces EUR 19 million Series B financing backed by international investors New investment to fuel continued growth of...
GEN-011 neoantigen-targeted peripheral T cell therapy clinical trial continues Strong presence at the SITC 36th Annual Meeting Conference call today...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives...
-Financing Will Pave Way for Expansion of Product Portfolio and Global Footprint & Provides Sufficient Resources to Deliver on Key...
Company celebrates three consecutive years of leading e-prescription accuracy for Tier 1 EHRs, adds RxChange Champion award to its accolades...
Early detection of viral infections may be as easy as wearing a smartwatch physIQ app embedded in watch collects physiological...
Company Placing Renewed Emphasis on the Country’s ‘Stroke Belt’, Increasing its Commitment to Address the Growing Needs of Stroke Patients...